MedTrace Logo

Dermal and Subcutaneous Augmentation and Skin Assessment After Fat-, Stem Cell and Scaffold Injections

NCT05079243 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2022-11-28

No results posted yet for this study

Summary

Investigate the effect of dermal/subcutaneous injection of ASC enriched fat transplant in a protective natural scaffold, designed to sustain the ASC viability after dermal/subcutaneous injection.

Conditions

  • Augmentation
  • Reconstruction

Interventions

BIOLOGICAL

Scaffold and adipose-derived stromal cell enriched fat grafts

eight different solutions of fat, ASCs, scaffold and CO2 laser in dermis three different solutions of fat, ASCs and scaffold in the subcutaneous layer

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER

  • Aleris-Hamlet Hospitaler København

    collaborator OTHER

  • Stemform

    lead INDUSTRY

Principal Investigators

  • Frederik P Mamsen · StemMedical A/S

  • stig-Frederik T Koelle, MD, PhD · StemMedical A/S

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-04
Primary Completion
2022-12-01
Completion
2023-06-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05079243 on ClinicalTrials.gov